Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004–2021

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae344Source: DataRank Database

Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004–2021 is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.20)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Vlad Novitsky,Jon A. Steingrimsson ORCID,Fizza S. Gillani ORCID,Mark Howison ORCID,Katherine Nagel ORCID

Live enrichment

PubMed:39041648 PMC:PMC11646588 OpenAlex:https://openalex.org/W4400932537

National Institutes of Health

Grant: R01AI136058

National Institutes of Health

Grant: K24AI134359

National Institutes of Health

Grant: P30AI042853

FWCI

1.20

Citation Percentile

0.8%

Citation Trend

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11646588/pdf/jiae344.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae344/58619049/jiae344.pdf

publisherhttps://academic.oup.com/jid/article-pdf/230/6/1422/61141385/jiae344.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11646588

Fields of Study

HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV Research and TreatmentHumansHIV-1HIV InfectionsRhode IslandMaleFemaleAdultMiddle AgedDrug Resistance, ViralAnti-HIV AgentsYoung AdultAdolescentReverse Transcriptase Inhibitors

MeSH Terms

AdolescentAdultFemaleHumansMaleMiddle AgedRhode IslandHIV-1HIV InfectionsReverse Transcriptase InhibitorsAnti-HIV AgentsDrug Resistance, ViralYoung Adult

Keywords

Reverse transcriptaseIntegraseDrug resistanceVirologyMedicineReverse-transcriptase inhibitorIntegrase inhibitorHIV drug resistanceRegimenProteaseDrugPharmacologyInternal medicineAntiretroviral therapyHuman immunodeficiency virus (HIV)BiologyViral loadPolymerase chain reactionGeneticsEnzymeAcquired Drug ResistanceHiv-1 Drug ResistanceMulticlass ResistanceOne-pill-once-daily Treatment OptionsTreatment Histories

Sustainable Development Goals

SDG 0: Good health and well-being